Trial
NCT03225846
Safety and Tolerability of WVE-120102 in Patients With Huntington's Disease
Phase ITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Wave Life Sciences USA, Inc.
Collaborators
—
Condition
Huntington's Disease
Intervention
WVE-120102
Why stopped
Lack of efficacy
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-04-25